Loading...
•
Dec 31, 2023
Radnet Q4 2023 Earnings Report
RadNet reported record revenue and adjusted EBITDA, released 2024 financial guidance, and formed a new digital health reporting segment.
Key Takeaways
RadNet reported a revenue of $420.4 million for Q4 2023, a 9.5% increase from Q4 2022. The company experienced a net loss of $1.9 million, and adjusted earnings per share was $0.20. They are also forming a new Digital Health reporting segment.
Record revenue and Adjusted EBITDA in Q4 enabled RadNet to exceed its 2023 full-year revised guidance ranges.
The core Imaging Center segment experienced same-center procedural volume growth of 5.5% and revenue growth of 8.6% compared to Q4 2022.
RadNet carefully managed liquidity and financial leverage, with net debt to Adjusted EBITDA falling below 2.0x at year-end 2023 and a cash balance of $342 million.
The company projects to open approximately a dozen new facilities during 2024 and expects to continue expanding existing health system joint ventures and partnerships.
Forward Guidance
RadNet anticipates significant growth in both the Imaging Center and Digital Health segments in 2024.
Positive Outlook
- Benefit from a continued focus on same-center performance.
- Benefit from tuck-in acquisitions.
- Benefit from increased reimbursement.
- Benefit from expanded and new health system joint ventures.
- Benefit from de novo center openings.
Challenges Ahead
- Continued commitment to capital expenditures in 2024, primarily on de novo center openings.
- Substantial investment in the development of DeepHealth OS cloud-based operating system.
- Generative AI modules that could lower costs and increase efficiency in areas of patient scheduling.
- Generative AI modules that could lower costs and increase efficiency in areas of pre-authorization.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...